Literature DB >> 16697011

Sterol regulatory element-binding protein-2 negatively regulates low density lipoprotein receptor-related protein transcription.

V Llorente-Cortés1, P Costales, J Bernués, S Camino-Lopez, L Badimon.   

Abstract

Low density lipoprotein receptor-related protein (LRP1) binds aggregated LDL (agLDL) leading to a high intracellular cholesteryl ester (CE) accumulation. AgLDL up-regulates LRP1 expression concomitantly with an LDL receptor (LDLR) and sterol regulatory element binding protein (SREBP-2) down-regulation. The objectives were to investigate whether SREBP-2 regulates LRP1 transcription and determine the molecular mechanisms involved in the process. Down-regulation of active SREBP-2 by nLDL and agLDL led to LDLR down-regulation and LRP1 up-regulation. Enforced expression of an active form of SREBP-2 (SREBP-2-NT, amino acid residues 1-468) decreased LRP1 expression and LRP1 promoter (WT-LRP1) luciferase activity in a dose-dependent manner. LDL did not exert any significant effect on LRP1 promoter activity when a putative sterol regulatory element (SRE) (5-GTGGGGTGA-3'; +225 to +233) was mutated (SRE-MT-LRP1). SREBP-2 overexpression exerted stronger down-regulatory effects on WT-LRP1 than on SRE-MT-LRP1 promoter activity both in control, nLDL- and agLDL-exposed HeLa cells. Gel mobility shift assays showed that recombinant SREBP-2-NT protein (1-468) binds to a double-stranded LRP1 DNA fragment (215 to 245) containing a wild-type (wt) SRE sequence but not to a mutated SRE (mt) sequence (5-GAATTCGA-3'). Our results demonstrate that LDL stimulates LRP1 transcription and decreases SREBP-2 active form which negatively regulates LRP1 transcription. SRE sequence (+225 to +233) plays a pivotal role for the down-regulatory effect of SREBP-2 on LRP1 promoter activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697011     DOI: 10.1016/j.jmb.2006.04.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes.

Authors:  Lauren K Fong; Max M Yang; Rodrigo Dos Santos Chaves; Sol M Reyna; Vanessa F Langness; Grace Woodruff; Elizabeth A Roberts; Jessica E Young; Lawrence S B Goldstein
Journal:  J Biol Chem       Date:  2018-06-01       Impact factor: 5.157

2.  GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.

Authors:  Ethan A Winkler; Yoichiro Nishida; Abhay P Sagare; Sanket V Rege; Robert D Bell; David Perlmutter; Jesse D Sengillo; Sara Hillman; Pan Kong; Amy R Nelson; John S Sullivan; Zhen Zhao; Herbert J Meiselman; Rosalinda B Wendy; Jamie Soto; E Dale Abel; Jacob Makshanoff; Edward Zuniga; Darryl C De Vivo; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2015-03-02       Impact factor: 24.884

3.  Effects and relationship of intermittent hypoxia on serum lipid levels, hepatic low-density lipoprotein receptor-related protein 1, and hypoxia-inducible factor 1α.

Authors:  Peng Li; Jian Wu; Li Zhao; Xue-Wei Feng
Journal:  Sleep Breath       Date:  2015-06-18       Impact factor: 2.816

4.  K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells.

Authors:  Paula Costales; Pablo Fuentes-Prior; Jose Castellano; Elena Revuelta-Lopez; Maria Ángeles Corral-Rodríguez; Laura Nasarre; Lina Badimon; Vicenta Llorente-Cortes
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

5.  SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.

Authors:  Robert D Bell; Rashid Deane; Nienwen Chow; Xiaochun Long; Abhay Sagare; Itender Singh; Jeffrey W Streb; Huang Guo; Anna Rubio; William Van Nostrand; Joseph M Miano; Berislav V Zlokovic
Journal:  Nat Cell Biol       Date:  2008-12-21       Impact factor: 28.824

Review 6.  Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Authors:  Robert D Bell; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2009-03-25       Impact factor: 17.088

7.  Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease.

Authors:  Lina Badimon; Teresa Padró; Gemma Vilahur
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-04

Review 8.  Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.

Authors:  Veronica Galvan; Matthew J Hart
Journal:  Biochim Biophys Acta       Date:  2015-11-27

9.  Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia.

Authors:  Elizabeth A O'Hare; Xiaochun Wang; May E Montasser; Yen-Pei C Chang; Braxton D Mitchell; Norann A Zaghloul
Journal:  J Lipid Res       Date:  2014-09-08       Impact factor: 5.922

10.  Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism.

Authors:  Jae Hoon Moon; Hyung Jun Kim; Hyun Min Kim; Sung Hee Choi; Soo Lim; Young Joo Park; Hak Chul Jang; Bong Soo Cha
Journal:  Thyroid       Date:  2013-08-28       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.